Research Article
Antiphospholipid Antibodies in Women Undergoing In Vitro Fertilization Treatment: Clinical Value of IgA Anti-β2glycoprotein I Antibodies Determination
Table 1
IVF cycles and pregnancy outcome in aPL positive and negative IVF treated patients.
| IVF treated patients
() | aPL positive patients
() | aPL negative patients
() | value |
| Patients with secondary infertility (%)
(before IVF attempts) | 37.5%
(3/8) | 15.6%
(5/32) | >0.05 |
| | Mean number of IVF attempts/patient | | | >0.05 | | Mean number of pregnancies after IVF/patient |
() |
() | >0.05 |
| | Outcome of IVF pregnancies | | | | | Abnormal outcome | | | | | Ectopic pregnancies/pregnancy | 0% | 11.7% (2/17)* | <0.05* | Early miscarriages/pregnancy
| 25% (1/4)
| 52.9% (9/17)*
| Fetal death in utero or premature delivery (preeclampsia)/pregnancy
| 75% (3/4) | 0%* | | Normal outcome | | | | | Full-term live birth/pregnancy | 0% | 35.3% (6/17) | |
|
|
